1-(3-Chloro-2-Hydroxypropyl)-2-Methyl-5-Nitroimidazole; 1-Chloro-3-(2-Methyl-5-Nitro-1H-Imidazol-1-Yl)-2-Propanol; 1-Chloro-3-(2-Methyl-5-Nitro-1H-Imidazol-1-Yl)Propan-2-Ol; 1-Chloro-3-(2-Methyl-5-Nitroimidazol-1-Yl)Propan-2-Ol; Ornidazol A-(Chloromethyl)-2-Methyl-5-Nitro-1H-Imidazole-1-Ethanol; Alpha-(Chlormethyl)-2-Methyl-5-Nitro-Imidazol-1-Aethanol; Alpha-(Chloromethyl)-2-Methyl-5-Nitro-1H-Imidazole-1-Ethano; Ro7-0207

Brief Introduction

Ornidazole is the third generation of nitroimidazole, which has obvious antibacterial advantages over metronidazole and Tinidazole. The half-life of plasma elimination of ornidazole is 14.4 hours, which is higher than that of metronidazole (8.4 hours) and Tinidazole (12.7 hours). Therefore, ornidazole can reduce the times of taking medicine and is more convenient to use. It acts on the DNA of anaerobes, amoebas, Giardia and Trichomonas cells to break their helix structure or prevent their transcription and replication, resulting in the death of pathogenic bacteria. The peak plasma concentration was reached 2 hours after oral administration, and the bioavailability was about 90%.

N-[[2-Methoxy-5-[5-(Trifluoromethyl)Tetrazol-1-Yl]Phenyl]Methyl]-2-Phenylpiperidin-3-Amine

CAS:168266-90-8

Molecular Formula:C21H23F3N6O

Brief Introduction

Vofopitant (GR-205,171) is a drug which acts as an NK1 receptor antagonist. It has antiemetic effects as with other NK1 antagonists, and also shows anxiolytic actions in animals. It was trialled for applications such as the treatment of social phobia and post-traumatic stress disorder, but did not prove sufficiently effective to be marketed.

2,4-Dimethylcinnamic Acid

CAS:1685-80-9

Molecular Formula:C11H12O2

Alias

More Information

(2E)-3-(2,4-Dimethylphenyl)Acrylic Acid; 3-(2,4-Dimethylphenyl)Acrylic Acid; (E)-3-(2,4-Dimethylphenyl)Prop-2-Enoic Acid; 3-(2,4-Dimethylphenyl)Prop-2-Enoic Acid; 2-Propenoic Acid, 3-(2,4-Dimethylphenyl)-

Brief Introduction

This product is an organic synthetic intermediate and can be used as a pharmaceutical intermediate.

3,5-Dimethoxycinnamic Acid

CAS:16909-11-8

Molecular Formula:C11H12O4

Alias

More Information

Imethoxycinnamic Acid; 3-(3,5-Dimethoxyphenyl)Acrylic Acid; 3,5-Dimethoxy Cinnamic Acid; 3-(3,5-Dimethoxyphenyl)Propenoic Acid

Brief Introduction

This product is an organic acid, which can be used as pharmaceutical raw materials and intermediates.

2,2-Dimethyl-7-(3-Methyloctan-2-Yl)-4-Pyridin-4-Ylchromen-5-Ol

CAS:16985-03-8

Molecular Formula:C25H33NO2

Alias

More Information

2-Methyl-4-<Pyridyl-(4)>-5-Hydroxy-6-<3-Methyloctyl-(2)>-2H-Chromenyl-(2)-Oxymagnesiumbromid; Nonabino; 2,2-Dimethyl-7-(3-Methyloctan-2-Yl)-4-(Pyridin-4-Yl)-2H-Chromen-5-Ol; 7-(1,2-Dimethyl-Heptyl)-2,2-Dimethyl-4-Pyridin-4-Yl-2H-Chromen-5-Ol; Nonabinum [Inn-Latin]; 2,2-Dimethyl-7-(3-Methyl-2-Octyl)-4-(4-Pyridyl)-2H-Chromen-5-Ol; 2,2-Dimethyl-5-Hydroxy-7-(3-Methyl-2-Octyl)-4-(4-Pyridyl)-2H-1-Benzopyran; Nonabine; Nonabinum; Nonabino [Inn-Spanish]; Unii-77Duk856J7; Brl-4664; 77Duk856J7

Brief Introduction

Nonabine (BRL-4664) is a drug which is a cannabinoid derivative, which was developed for the prevention of nausea and vomiting associated with cancer chemotherapy. It has strong antiemetic effects equivalent to those of chlorpromazine, and also produces some mild sedative effects, along with dry mouth and EEG changes typical of cannabinoid agonists, but with minimal changes in mood or perception, suggesting the abuse potential is likely to be low.

Inquiry (

/ 10

)

Clear All